Mulberry Compounds Outdock a Clinical Cancer Drug in CDK1 Simulation Study
Mulberry Compounds Outdock a Clinical Cancer Drug in CDK1 Simulation Study Bioengineer.org
Mulberry Compounds Outdock a Clinical Cancer Drug in CDK1 Simulation Study Bioengineer.org
Researchers Reveal How Aggressive Breast Cancer May Spread to the Brain SciTechDaily
В России нашли новый способ оценки эффективности терапии рака Наука Mail
Northeast GI Oncology Congress 2026: Bringing the GI Oncology Community Together Oncodaily
Haystack MRD Accurately Predicts Colorectal Cancer Recurrence, Study Finds Clinical Lab Products
Top 4 Liver Cancer Research Opportunities to Apply for in 2026–2027 Oncodaily
Natera, Alliance Foundation Trials Launch Phase III Trial for MRD-Guided Treatment in Breast Cancer Genome Web
Clinical Update from the Ongoing Phase 2 Trial of PRV111, the First Non-Surgical Therapy in Development for Early-Stage Oral Cancer Morningstar
Clinical Update from the Ongoing Phase 2 Trial of PRV111, the First Non-Surgical Therapy in Development for Early-Stage Oral Cancer PR Newswire
American Cancer Society researchers stress lack of access to health insurance and screening as barriers to progress
Los investigadores de la American Cancer Society destacan que la falta de acceso al seguro médico y a las pruebas de detección son obstáculos para el progreso
The partnership’s Crucial Catch initiative works to improve cancer outcomes nationwide by addressing access to cancer screening.
Phase III Trial Tests Blood-Based MRD Monitoring to Spare Breast Cancer Patients CDK4/6 Inhibitor Toxicity Bioengineer.org